Increased regulatory scrutiny on psychedelic biotech companies.
Biogen and Eli Lilly are actively pursuing acquisitions.
Doctors Without Borders raises concerns about Gilead's practices.
Briefing: Psychedelic Biotechs Under Scrutiny for YouTube Promotions
Strategic angle: Biogen and Eli Lilly make takeover moves, while Doctors Without Borders criticizes Gilead amidst growing concerns in the biotech sector.